- Combination therapy patterns and predictors of ADHD in commercially insured and Medicaid populationsCliff Molife
Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN 46285, USA
Postgrad Med 124:7-22. 2012..Little is known about the current prevalence and predictors of combination therapy. This analysis describes ADHD medication use focusing on combination versus monotherapy...
- Assessment of patient-reported outcomes of insulin pen devices versus conventional vial and syringeCliff Molife
Eli Lilly and Company, Lilly Research Laboratories, Indianapolis, IN 46285, USA
Diabetes Technol Ther 11:529-38. 2009..These findings have potential clinical and policy implications for patients, diabetes care providers, and/or payers to make evidence-based decisions regarding ways to facilitate initiation and management of insulin therapy...